PMA P160045S052

Device
Oncomine™ Dx Target Test
Applicant
Life Technologies Corporation
PMA number
P160045
Supplement
S052
Product code
PQP
Decision date
2026-03-04
Classification
Pathology
Generic name
Next generation sequencing oncology panel, somatic or germline variant detection system
Approval order statement
approval for an increase in quality control sampling of components during the QC release process

Current openFDA PMA Record#

Device
Oncomine™ Dx Target Test
Applicant
Life Technologies Corporation
PMA number
P160045
Supplement
S052
Product code
PQP
Generic name
Next generation sequencing oncology panel, somatic or germline variant detection system
Decision date
2026-03-04
Decision code
APPR
Date received
2026-01-20
Supplement type
Special (Immediate Track)
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Approval order statement
approval for an increase in quality control sampling of components during the QC release process